CytoReason’s machine-learning platform will help the pharma giant find the fastest route to new drug targets for autoimmune diseases.
Read more here.
CytoReason’s machine-learning platform will help the pharma giant find the fastest route to new drug targets for autoimmune diseases.
Read more here.
![[JumpCloud in MENAFN] Jumpcloud recognized by expert insights as top solution for summer 2023 in five categories](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
